typical starting dose of tirzepatide Zepbound® Dosage Guide The Complete Tirzepatide Dosage Chart

We believe in a patient-first approach, which means being honest about all options

A qualitative sub-study of the trial by Whicher and colleagues 144 over 17 patients with overweight or obesity and schizophrenia-spectrum disorders found that most of the interviewees and their clinicians had had positive experiences regarding GLP-1RA administrations

In 2025, the company reported a modest +0.99% YoY revenue growth, but the underlying story is more interesting: Dupixent ($17.8B) remains the clear growth engine, benefiting from expanding indications like COPD and broader patient reach, while the EYLEA franchise ($7.89B) continues to be a core contributor despite facing biosimilar pressure, supported by the transition to EYLEA HD, and Libtayo ($1.45B) is steadily gaining ground in oncology, particularly in lung cancer settings

Licensed providers review your health information and determine which option, if any, may be included as part of your program

[DOI] [PubMed] [Google Scholar] 82.Kellar D., Craft S

Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women